Intersect ENT

Results: 36



#Item
31Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant, Allowing More Chronic Sinusitis Patients to Benefit from Localized Drug Delivery PROPEL™ mini Offers Same Clinical Benefits and Dose of Mometasone

Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant, Allowing More Chronic Sinusitis Patients to Benefit from Localized Drug Delivery PROPEL™ mini Offers Same Clinical Benefits and Dose of Mometasone

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-04-17 10:10:29
32Media Contact: Nicole Osmer[removed]removed] Intersect ENT Quadruples Operation Size with Expansion to New Facility in Menlo Park, Calif.

Media Contact: Nicole Osmer[removed]removed] Intersect ENT Quadruples Operation Size with Expansion to New Facility in Menlo Park, Calif.

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-04-17 10:11:54
33Intersect ENT Announces Publication of Positive Data from Three Studies of Company’s Drug-Eluting Sinus Implants Results Published in International Forum of Allergy & Rhinology Add to Clinical Evidence Supporting Benef

Intersect ENT Announces Publication of Positive Data from Three Studies of Company’s Drug-Eluting Sinus Implants Results Published in International Forum of Allergy & Rhinology Add to Clinical Evidence Supporting Benef

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-10-08 16:52:23
34Study Indicates Cost Effectiveness of Intersect ENT’s PROPEL Implant for Chronic Sinusitis Study Author Assesses Significant Productivity Loss from Chronic Sinusitis Menlo Park, Calif. – Aug 11, 2014 – Intersect EN

Study Indicates Cost Effectiveness of Intersect ENT’s PROPEL Implant for Chronic Sinusitis Study Author Assesses Significant Productivity Loss from Chronic Sinusitis Menlo Park, Calif. – Aug 11, 2014 – Intersect EN

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-08-11 09:42:48
35Intersect ENT Announces Pricing of its Initial Public Offering Menlo Park, Calif. – July 24, 2014 – Intersect ENT, Inc., a commercial drug-device company committed to improving the quality of life for patients with e

Intersect ENT Announces Pricing of its Initial Public Offering Menlo Park, Calif. – July 24, 2014 – Intersect ENT, Inc., a commercial drug-device company committed to improving the quality of life for patients with e

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-07-24 07:55:15
36Intersect ENT Announces Appointment of Chief Financial Officer Jeryl Hilleman Menlo Park, Calif. – June 4, 2014 – Intersect ENT, Inc., a commercial stage drug-device company committed to improving the quality of life

Intersect ENT Announces Appointment of Chief Financial Officer Jeryl Hilleman Menlo Park, Calif. – June 4, 2014 – Intersect ENT, Inc., a commercial stage drug-device company committed to improving the quality of life

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-06-04 20:41:13